5.0
2 Aug 2022
Former employee, more than 10 years
South San Francisco, CA
Recommend
CEO approval
Business outlook
Pros
Talented, collaborative colleagues Amazing benefits Focus on patients
Cons
Many colleagues have left for smaller biotech startups Less autonomous now than it was before the Roche integration